This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Reply to Letter to the Editor "Omission of Bupropion as a Recommended Treatment for PTSD"

Article Abstract

Letter to the Editor

Sir: We are pleased to reply to Dr. Reeves’ letter concerning the issue of treatment selection for posttraumatic stress disorder (PTSD) as reported in the Expert Consensus Guideline Series. Experts who were chosen responded according to their personal experience and also their understanding of what is in the literature with respect to making treatment recommendations. Bupropion was included as one possible approach (Guideline 35) and received a rating of 5 (i.e., equivocal, a second-line treatment that would sometimes be used) from the standpoint of representing the best combination of effectiveness, safety, and tolerability. At the time the guidelines were assembled, reported efficacy for bupropion in PTSD was extremely limited.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 61

Quick Links: Depression (MDD)